Wright Medical Group NV (Wright Medical Group NV) Float Percentage Of Total Shares Outstanding : 98.51% (As of May. 05, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Wright Medical Group NV's float shares is 127.99 Mil. Wright Medical Group NV's total shares outstanding is 129.93 Mil. Wright Medical Group NV's float percentage of total shares outstanding is 98.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Wright Medical Group NV's Insider Ownership is 2.72%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Wright Medical Group NV's Institutional Ownership is 53.58%.

Wright Medical Group NV Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Wright Medical Group NV's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	127.99	/	129.93
	=	98.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wright Medical Group NV (Wright Medical Group NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB

Website

http://www.wright.com

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Executives

Steven P. Wallace	officer: President, International	1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan	officer: SVP, Operations	1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith	officer: SVP, Quality and Regulatory	1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper	officer: SVP, Chief Digital Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier	officer: President, Upper Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher	officer: President, Lower Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter	officer: SVP, Chief Compliance Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews	officer: SVP, Global Finance	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker	officer: SVP, Process Improvement	5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton	officer: SVP, Chief Human Resources Ofr	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry	officer: EVP, Chief Finan./Op. Officer	5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey	officer: SVP, Chief Comm. Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell	officer: EVP, Chief Global Comm Officer	C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano	director, officer: President and Chief Executive	110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke	officer: Pres. Emerging Markets AUS/JAP	5677 AIRLINE ROAD ARLINGTON TN 38002